Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1689
Full metadata record
DC FieldValueLanguage
dc.contributorKhanina, A.en_US
dc.contributorUrbancic, K.en_US
dc.contributorHaeusler, G.en_US
dc.contributorKong, David C. M.en_US
dc.contributorDouglas, A.en_US
dc.contributorTio, S.en_US
dc.contributorWorth, L.en_US
dc.contributorSlavin, M.en_US
dc.contributorThursky, K.en_US
dc.date.accessioned2021-01-06T05:51:25Z-
dc.date.available2021-01-06T05:51:25Z-
dc.date.issued2021-
dc.identifier.govdoc01658en_US
dc.identifier.urihttp://hdl.handle.net/11054/1689-
dc.description.abstractBackground: Guidance on assessment of the quantity and appropriateness of antifungal prescribing is required to assist hospitals to interpret data effectively and structure quality improvement programmes. Objectives: To achieve expert consensus on a core set of antifungal stewardship (AFS) metrics and to determine their feasibility for implementation. Methods: A literature review was undertaken to develop a list of candidate metrics. International experts were invited to participate in sequential web-based surveys to evaluate the importance and feasibility of metrics in the area of AFS using Delphi methodology. Three surveys were completed. Consensus was predefined as ≥80% agreement on the importance of each metric. Results: Eighty-two experts consented to participate from 17 different countries. Response rate for each survey was >80%. The panel included adult and paediatric physicians, microbiologists and pharmacists with diverse content expertise. Consensus was achieved for 38 metrics considered important to routinely include in AFS programmes, and related to antifungal consumption (n = 5), quality of antifungal prescribing and management of invasive fungal infection (IFI) (n = 24), and clinical outcomes (n = 9). Twenty-one consensus metrics were considered to have moderate to high feasibility for routine collection. Conclusions: The identified core AFS metrics will provide a framework to comprehensively assess the quantity and quality of antifungal prescribing within hospitals to develop quality improvement programmes aimed at improving IFI prevention, management and patient-centred outcomes. A standardized approach will support collaboration and benchmarking to monitor the efficacy of current prophylaxis and treatment guidelines, and will provide important feedback to guideline developers.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2021-01-06T05:11:56Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2021-01-06T05:51:25Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2021-01-06T05:51:25Z (GMT). No. of bitstreams: 0 Previous issue date: 2020en
dc.titleEstablishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey.en_US
dc.typeJournal Articleen_US
dc.type.specifiedArticleen_US
dc.bibliographicCitation.titleJournal of Antimicrobial Chemotherapyen_US
dc.bibliographicCitation.volume76en_US
dc.bibliographicCitation.issue1en_US
dc.bibliographicCitation.stpage253en_US
dc.bibliographicCitation.endpage262en_US
dc.subject.healththesaurusANTIFUNGAL AGENTSen_US
dc.subject.healththesaurusAPPROPRIATENESSen_US
dc.subject.healththesaurusPRESCRIBING BEHAVIORen_US
dc.subject.healththesaurusCONSENSUSen_US
dc.identifier.doihttps://doi.org/10.1093/jac/dkaa409en_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.